PortfoliosLab logoPortfoliosLab logo
CRDL vs. LAC
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

CRDL vs. LAC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Cardiol Therapeutics Inc Class A (CRDL) and Lithium Americas Corp. (LAC). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CRDL achieves a 20.57% return, which is significantly higher than LAC's 19.27% return.


CRDL

1D
-5.74%
1M
-16.06%
YTD
20.57%
6M
23.74%
1Y
-7.26%
3Y*
19.84%
5Y*
-15.74%
10Y*

LAC

1D
-9.57%
1M
-6.14%
YTD
19.27%
6M
-0.95%
1Y
96.97%
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

CRDL vs. LAC - Yearly Performance Comparison


2026 (YTD)202520242023
CRDL
Cardiol Therapeutics Inc Class A
20.57%-25.48%51.80%-4.18%
LAC
Lithium Americas Corp.
19.27%46.80%-53.59%-36.82%

Correlation

The correlation between CRDL and LAC is 0.22, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.22

Correlation (All Time)
Calculated using the full available price history since Oct 3, 2023

0.18

Fundamentals

Market Cap

CRDL:

$115.30M

LAC:

$1.84B

EPS

CRDL:

-$0.38

LAC:

-$0.28

PB Ratio

CRDL:

6.45

LAC:

1.36

Total Revenue (TTM)

CRDL:

$0.00

LAC:

$0.00

Gross Profit (TTM)

CRDL:

-$25.95K

LAC:

-$580.22K

EBITDA (TTM)

CRDL:

-$34.00M

LAC:

-$52.10M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CRDL vs. LAC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CRDL
CRDL Risk / Return Rank: 3636
Overall Rank
CRDL Sharpe Ratio Rank: 3636
Sharpe Ratio Rank
CRDL Sortino Ratio Rank: 3838
Sortino Ratio Rank
CRDL Omega Ratio Rank: 3838
Omega Ratio Rank
CRDL Calmar Ratio Rank: 3434
Calmar Ratio Rank
CRDL Martin Ratio Rank: 3535
Martin Ratio Rank

LAC
LAC Risk / Return Rank: 7171
Overall Rank
LAC Sharpe Ratio Rank: 6464
Sharpe Ratio Rank
LAC Sortino Ratio Rank: 8282
Sortino Ratio Rank
LAC Omega Ratio Rank: 7777
Omega Ratio Rank
LAC Calmar Ratio Rank: 6969
Calmar Ratio Rank
LAC Martin Ratio Rank: 6262
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CRDL vs. LAC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Cardiol Therapeutics Inc Class A (CRDL) and Lithium Americas Corp. (LAC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


CRDLLACDifference

Sharpe ratio

Return per unit of total volatility

-0.10

0.74

-0.85

Sortino ratio

Return per unit of downside risk

0.37

2.48

-2.11

Omega ratio

Gain probability vs. loss probability

1.04

1.29

-0.24

Calmar ratio

Return relative to maximum drawdown

-0.20

1.55

-1.75

Martin ratio

Return relative to average drawdown

-0.30

2.41

-2.70

CRDL vs. LAC - Sharpe Ratio Comparison

The current CRDL Sharpe Ratio is -0.10, which is lower than the LAC Sharpe Ratio of 0.74. The chart below compares the historical Sharpe Ratios of CRDL and LAC, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


CRDLLACDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.10

0.74

-0.85

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.18

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.17

-0.22

+0.05

Drawdowns

CRDL vs. LAC - Drawdown Comparison

The maximum CRDL drawdown since its inception was -92.71%, which is greater than LAC's maximum drawdown of -81.83%. Use the drawdown chart below to compare losses from any high point for CRDL and LAC.


Loading charts...

Drawdown Indicators


CRDLLACDifference

Max Drawdown

Largest peak-to-trough decline

-92.71%

-81.83%

-10.88%

Max Drawdown (1Y)

Largest decline over 1 year

-39.87%

-63.08%

+23.21%

Max Drawdown (3Y)

Largest decline over 3 years

-72.73%

Max Drawdown (5Y)

Largest decline over 5 years

-90.72%

Current Drawdown

Current decline from peak

-81.42%

-55.63%

-25.79%

Average Drawdown

Average peak-to-trough decline

-68.96%

-63.24%

-5.72%

Ulcer Index

Depth and duration of drawdowns from previous peaks

26.96%

40.46%

-13.50%

Volatility

CRDL vs. LAC - Volatility Comparison

The current volatility for Cardiol Therapeutics Inc Class A (CRDL) is 10.49%, while Lithium Americas Corp. (LAC) has a volatility of 20.68%. This indicates that CRDL experiences smaller price fluctuations and is considered to be less risky than LAC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CRDLLACDifference

Volatility (1M)

Calculated over the trailing 1-month period

10.49%

20.68%

-10.19%

Volatility (6M)

Calculated over the trailing 6-month period

43.07%

51.62%

-8.55%

Volatility (1Y)

Calculated over the trailing 1-year period

70.34%

131.32%

-60.98%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

87.04%

101.32%

-14.28%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

87.09%

101.32%

-14.23%

Dividends

CRDL vs. LAC - Dividend Comparison

Neither CRDL nor LAC has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

CRDL vs. LAC - Financials Comparison

This section allows you to compare key financial metrics between Cardiol Therapeutics Inc Class A and Lithium Americas Corp.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00K40.00K60.00K80.00K2022202320242025202600
(CRDL) Total Revenue
(LAC) Total Revenue
Values in USD except per share items

Frequently Asked Questions


CRDL and LAC have a correlation of 0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

LAC has higher volatility (20.68%) compared to CRDL (10.49%). In terms of maximum drawdown, CRDL dropped -92.71% vs LAC's -81.83%.

LAC currently has the higher Sharpe Ratio (0.74 vs -0.10), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CRDL and LAC

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer